StoxMaitreya Medicare Limited
NSE: MAITREYA · Unclassified
Ask the data
Instant answers about Maitreya Medicare Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Revenue | 47.5 | 46.7 | 44.9 |
| EBITDA | 5.8 | 4.9 | -0.3 |
| Operating margin | 12.2% | 10.4% | -0.7% |
| Interest | 0.8 | 0.8 | 1.5 |
| Depreciation | 1.3 | 1.4 | 1.5 |
| Profit before tax | 4.0 | 3.2 | -2.5 |
| Tax | 1.2 | 1.3 | -0.0 |
| Net profit | 2.8 | 1.9 | -2.5 |
| EPS ₹ | 0.00 | 0.00 | -3.64 |
| Operating cash flow | -2.5 | 5.1 | 8.4 |
| Capex | 5.0 | 4.5 | 0.0 |
| Dividend paid | 0.4 | 0.0 | 0.0 |
| Total assets | — | 48.0 | 68.4 |
| Equity | — | 32.1 | 29.0 |
Half-yearly performance
last 7 half years · ₹ crore| H1 FY24 | H2 FY24 | H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 | H1 FY27 | |
|---|---|---|---|---|---|---|---|
| Revenue | 24.8 | 24.8 | 24.4 | 22.3 | 23.7 | 21.1 | 23.7 |
| Operating profit | 4.6 | 4.6 | 3.2 | 1.7 | 1.0 | -1.4 | 1.6 |
| Operating margin | 18.4% | 18.4% | 13.1% | 7.5% | 4.4% | -6.5% | 6.9% |
| Other income | 0.1 | 0.1 | 0.2 | 0.4 | 0.2 | 0.8 | 0.3 |
| Interest | 0.4 | 0.4 | 0.5 | 0.3 | 0.4 | 1.1 | 1.2 |
| Depreciation | 0.6 | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | 1.2 |
| Profit before tax | 3.6 | 3.6 | 2.3 | 0.9 | 0.1 | -2.5 | -0.4 |
| Tax | 1.0 | 1.0 | 0.5 | 0.8 | 0.1 | -0.1 | 0.5 |
| Net profit | 2.6 | 2.6 | 1.8 | 0.2 | -0.0 | -2.4 | -0.9 |
| EPS ₹ | 5.17 | 0.00 | 2.30 | 0.00 | -0.05 | -3.59 | -1.38 |
| Revenue YoY | — | — | -1.7% | -10.0% | -2.7% | -5.2% | -0.1% |
| Profit YoY | — | — | -31.6% | -92.2% | -102.3% | -1315.0% | — |
Returns & margins
trailing-twelve-month, per half year| H2 FY24 | H1 FY25 | H2 FY25 | H1 FY26 | H2 FY26 | H1 FY27 | |
|---|---|---|---|---|---|---|
| ROE | 30.0% | 13.5% | 6.1% | 0.5% | -8.5% | -12.0% |
| ROCE | 35.7% | 17.8% | 10.8% | 5.0% | -1.9% | -1.2% |
| Net margin | 10.3% | 8.8% | 4.2% | 0.3% | -5.5% | -7.5% |
| EBITDA margin | 18.4% | 15.7% | 10.4% | 5.9% | -0.7% | 0.6% |
| Debt / equity | 0.30 | 0.18 | 0.16 | 0.14 | 0.80 | 0.85 |
| Interest coverage | 10.18 | 7.95 | 5.01 | 2.28 | -0.66 | -0.28 |
| Asset turnover | 1.49 | 1.05 | 0.97 | 0.93 | 0.66 | 0.66 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '23 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|---|---|
| Share capital | 10.7 | 12.2 | 12.1 | 11.6 | 11.6 | 11.5 |
| Other equity / reserves | 6.4 | 19.7 | 19.9 | 19.9 | 17.5 | 16.5 |
| Total equity | 17.1 | 32.0 | 32.1 | 31.5 | 29.0 | 28.0 |
| Borrowings | 5.2 | 5.7 | 5.2 | 4.3 | 23.1 | 23.9 |
| Current liabilities | 10.5 | 9.3 | 10.8 | 13.5 | 15.9 | 16.2 |
| Non-current liabilities | 4.6 | 4.9 | 4.3 | 3.5 | 22.8 | 23.6 |
| Total assets | 33.2 | 47.0 | 48.0 | 49.2 | 68.4 | 68.4 |
| Property, plant & equipment | 11.0 | 15.1 | 15.3 | 16.3 | 40.8 | 40.8 |
| Investments | 0.8 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Inventories | 0.5 | 0.6 | 0.6 | 0.8 | 0.8 | 1.4 |
| Receivables | 15.0 | 13.8 | 15.0 | 14.4 | 11.0 | 10.9 |
| Cash & equivalents | 1.3 | 8.1 | 7.9 | 8.3 | 8.7 | 7.2 |
Cash flow
annual · ₹ crore · line = free cash flow| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Cash from operations | -2.5 | 5.1 | 8.4 |
| Cash from investing | -5.4 | -7.4 | -26.7 |
| Cash from financing | 12.2 | 3.7 | 19.0 |
| Capex | 5.0 | 4.5 | 0.0 |
| Free cash flow | -7.5 | 0.6 | 8.4 |
| Dividends paid | 0.4 | 0.0 | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Maitreya Medicare Limited | 83 | 121.80 | — | 2.95 | -12.0% |
StoxGud checklist: Bearish setup · 3/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Maitreya Medicare Limited?
Maitreya Medicare Limited (MAITREYA) closed at ₹121.80 on NSE on 06 Nov 2026.
What is the market cap of Maitreya Medicare Limited?
₹83 crore at the latest close.
How fast is Maitreya Medicare Limited growing?
Maitreya Medicare Limited: Latest-half-year revenue is down 0.1% year on year.
How profitable is Maitreya Medicare Limited?
On a trailing-twelve-month basis return on equity is -12.0%, return on capital employed -1.2%, operating margin 0.6%, net margin -7.5%.
How much debt does Maitreya Medicare Limited have?
Maitreya Medicare Limited is moderately geared: debt to equity is 0.85 with borrowings of ₹24 cr against cash of ₹7 cr (balance sheet of 2026-09-30). Operating profit covers interest -0.3 times.
Financials parsed from Maitreya Medicare Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY24, annual from FY24, balance sheet from Sep '23. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.